{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:47:25Z","timestamp":1789516045390,"version":"build-2803163510"},"reference-count":20,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Objective: This study was performed to evaluate the impact of cured differentiated thyroid carcinoma (DTC) on quality of life. Previous studies on quality of life in patients with DTC were hampered by small patient numbers or limited quality-of-life parameters or were uncontrolled.<\/jats:p>\n                  <jats:p>Design: This was a cross-sectional case-control study.<\/jats:p>\n                  <jats:p>Method: We assessed quality of life in 153 cured DTC patients with a median duration of cure of 6.34 yr (range 0.3\u201341.8) and studied the contribution of disease-specific, biochemical, and social variables, focusing on the degree of TSH suppression. Four validated health-related questionnaires were used (Short Form-36, Multidimensional Fatigue Index-20, Hospital Anxiety and Depression Scale, and Somatoform Disorder Questionnaire), including multiple aspects of physical, psychological, and social functioning. Patients were compared with 113 controls selected by patients themselves (control group I) and 336 pooled age- and gender-matched controls from other Leiden quality-of-life studies (control group II).<\/jats:p>\n                  <jats:p>Results: Patients had significantly decreased quality of life in 11 of 16 subscales when compared with control group I. In comparison with control group II, decreased scores in 13 of 16 items were observed. An important independent predictor for quality of life was duration of cure. Quality-of-life parameters were not influenced by serum TSH levels both measured at the time of quality-of-life assessment and measured over time since initial therapy.<\/jats:p>\n                  <jats:p>Conclusions: Patients cured for DTC have impaired quality of life, independently of TSH level. Quality-of-life parameters were inversely affected by duration of cure and consequently may be restored after prolonged follow-up.<\/jats:p>","DOI":"10.1210\/jc.2007-1203","type":"journal-article","created":{"date-parts":[[2007,10,23]],"date-time":"2007-10-23T21:01:18Z","timestamp":1193173278000},"page":"200-203","source":"Crossref","is-referenced-by-count":136,"title":["Quality of Life in Cured Patients with Differentiated Thyroid Carcinoma"],"prefix":"10.1210","volume":"93","author":[{"given":"Hendrieke C.","family":"Hoftijzer","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Leiden University Medical Centre, 2300 RC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A.","family":"Heemstra","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Leiden University Medical Centre, 2300 RC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora P. M.","family":"Corssmit","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Leiden University Medical Centre, 2300 RC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agatha A.","family":"van der Klaauw","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Leiden University Medical Centre, 2300 RC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes A.","family":"Romijn","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Leiden University Medical Centre, 2300 RC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes W. A.","family":"Smit","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Leiden University Medical Centre, 2300 RC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071613453706500_R1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1053\/beem.2000.0105","article-title":"Papillary and follicular thyroid carcinoma.","volume":"14","author":"Schlumberger","year":"2000","journal-title":"Baillieres Best Pract Res Clin Endocrinol Metab"},{"key":"2020071613453706500_R2","first-page":"1028","article-title":"Control of adrenergic overactivity by \u03b2-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine.","volume":"78","author":"Biondi","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613453706500_R3","first-page":"4701","article-title":"Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients.","volume":"85","author":"Biondi","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613453706500_R4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.arcmed.2005.05.008","article-title":"Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction.","volume":"37","author":"Gulseren","year":"2006","journal-title":"Arch Med Res"},{"key":"2020071613453706500_R5","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00520-003-0474-4","article-title":"Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy.","volume":"11","author":"Crevenna","year":"2003","journal-title":"Support Care Cancer"},{"key":"2020071613453706500_R6","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/BF03347258","article-title":"A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma.","volume":"28","author":"Giusti","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"2020071613453706500_R7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1258\/0022215041615137","article-title":"Quality of life of well-differentiated thyroid carcinoma patients.","volume":"118","author":"Dagan","year":"2004","journal-title":"J Laryngol Otol"},{"key":"2020071613453706500_R8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hed.10217","article-title":"Health profiles and quality of life of 518 survivors of thyroid cancer.","volume":"25","author":"Schultz","year":"2003","journal-title":"Head Neck"},{"key":"2020071613453706500_R9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/MLG.0b013e31802e3739","article-title":"Health-related quality of life in thyroid cancer survivors.","volume":"117","author":"Tan","year":"2007","journal-title":"Laryngoscope"},{"key":"2020071613453706500_R10","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2265.2006.02458.x","article-title":"Quality of life in long-term exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial.","volume":"64","author":"Eustatia-Rutten","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613453706500_R11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/thy.2006.16.109","article-title":"Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.","volume":"16","author":"Cooper","year":"2006","journal-title":"Thyroid"},{"key":"2020071613453706500_R12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1530\/eje.1.02114","article-title":"Quality of life in treated adult craniopharyngioma patients.","volume":"154","author":"Dekkers","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"2020071613453706500_R13","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1210\/jc.2004-1375","article-title":"Quality of life in patients after long-term biochemical cure of Cushing\u2019s disease.","volume":"90","author":"van Aken","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613453706500_R14","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1210\/jc.2004-0669","article-title":"Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess.","volume":"89","author":"Biermasz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613453706500_R15","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1210\/jc.2006-0003","article-title":"Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma.","volume":"91","author":"Dekkers","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613453706500_R16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00435982","article-title":"A comparison of two multidimensional measures of health status: the Nottingham Health Profile and the RAND 36-Item Health Survey 1.0.","volume":"5","author":"VanderZee","year":"1996","journal-title":"Qual Life Res"},{"key":"2020071613453706500_R17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","article-title":"The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue.","volume":"39","author":"Smets","year":"1995","journal-title":"J Psychosom Res"},{"key":"2020071613453706500_R18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale.","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"2020071613453706500_R19","year":"1980"},{"key":"2020071613453706500_R20","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/ijc.10981","article-title":"Health profiles in 5836 long-term cancer survivors.","volume":"104","author":"Schultz","year":"2003","journal-title":"Int J Cancer"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/93\/1\/200\/9053754\/jcem0200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/93\/1\/200\/9053754\/jcem0200.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T20:34:42Z","timestamp":1594931682000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/93\/1\/200\/2598504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2007-1203","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,1]]}}}